Old Web
English
Sign In
Acemap
>
authorDetail
>
O. Katopodis
O. Katopodis
Medicine
Metastatic pancreatic cancer
Gemcitabine/oxaliplatin
Erlotinib
Phases of clinical research
2
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
2014
Cancer Chemotherapy and Pharmacology
O. Katopodis
John Souglakos
Efstathios N. Stathopoulos
A. Christopoulou
E. Kontopodis
A. Kotsakis
K. Kalbakis
Nikolaos Kentepozidis
A. Polyzos
D. Hatzidaki
V. Georgoulias
Show All
Source
Cite
Save
Citations (11)
Elderly patients with fluoropyrimidine-resistant advanced colorectal cancer (CRC) derive similar benefit without excessive toxicity when treated with irinotecan monotherapy
2004
Journal of Clinical Oncology
G Stewart
Ian Chau
A. Norman
O. Katopodis
C. Topham
Gary Middleton
Mark Hill
P. Ross
J. Oates
D. Cunningham
Show All
Source
Cite
Save
Citations (5)
1
map